Investigational Site

Saint Petersburg, Russian Federation 197341

0 studies enrolling now · 2 studies all time

What they study most

Anemia, Anemia in Incident Dialysis Patients, Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

Studies at this site

• Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden — Stopped early
• Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants — Completed